Diagnosis and Management of Microscopic Colitis in Pediatric Patients

Salina Khushal1, Maria Oliva-Hemker2

  • 1Division of Pediatric Gastroenterology, Hepatology and Nutrition, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Paediatric Drugs
|May 2, 2022
PubMed

Insights

Microscopic colitis (MC) is a rare cause of chronic diarrhea in children. Early diagnosis requires awareness and colonoscopy with biopsy for effective management and symptom control.

Area of Science:

  • Gastroenterology
  • Pediatric Pathology
  • Inflammatory Bowel Disease

Background:

  • Microscopic colitis (MC) presents as chronic watery diarrhea, distinct histologic findings, and normal endoscopic appearance.
  • MC is a common cause of diarrhea in adults but infrequently reported in pediatric populations.
  • Non-specific symptoms and rarity in children necessitate increased awareness for timely diagnosis.

Purpose of the Study:

  • To review epidemiology, risk factors, clinical features, and diagnosis of pediatric MC.
  • To discuss current theories on pathogenesis and their impact on management.
  • To outline suggested management strategies for pediatric MC, focusing on symptom control and minimizing treatment adverse effects.

Main Methods:

  • Literature review of microscopic colitis in the pediatric population.
  • Synthesis of data on epidemiology, clinical presentation, diagnostic methods, pathogenesis theories, and treatment approaches.
  • Focus on evidence relevant to pediatric patients and clinicians.

Main Results:

  • MC diagnosis in children requires colonoscopy with biopsy due to normal endoscopic findings.
  • Etiology is not fully understood, but pathogenesis theories guide treatment.
  • Management aims for symptomatic improvement, minimizing adverse effects, and sustained remission, potentially requiring maintenance therapy.

Conclusions:

  • Increased awareness among pediatric clinicians and pathologists is crucial for diagnosing rare pediatric MC.
  • Timely diagnosis through colonoscopy and biopsy is essential.
  • Effective management involves symptomatic control, minimizing treatment risks, and addressing potential recurrence with maintenance therapy.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
436
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
236
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
208
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
358
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
255
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
328